Clinical features by disease duration in ulcerative colitis-associated cancers.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Miyakita Hiroshi, Yamamoto Seiichiro, Uchino Motoi, Hiroki Ikeuchi, Okabayashi Koji, Shiro Oka, Futami Kitaro, Itabashi Michio, Watanabe Kazuhiro, Shibutani Masatsune, Okita Yoshiki, Wakai Toshifumi, Mizuuchi Yusuke, Okamoto Kinya, Yamada Kazutaka, Sato Yu, Ogino Takayuki, Kimura Hideaki, Takahashi Kenichi, Hida Koya, Kinugasa Yusuke, Ishida Fumio, Okuda Junji, Daito Koji, Yamamoto Takayuki, Koyama Fumikazu, Hanai Tunekazu, Komori Koji, Shida Dai, Noguchi Tatsuki, Sugihara Kenichi, Ajioka Yoichi, Ishihara Soichiro, Study Group for Inflammatory Bowel Disease Associated Intestinal Cancers by the Japanese Society for Cancer of the Colon and Rectum
Аннотация
METHOD: This study analysed data from the Japan Society for Colorectal Cancer Research involving UC patients diagnosed with colorectal cancer. The sample consisted of 1200 patients, and their histological and clinicopathological features were analysed. Cutoff values were established at 5 and 15 years for comparisons. Trends and prognostic outcomes corresponding to disease duration were evaluated.
RESULTS: Comparison between two groups (disease duration 0-5 and >5 years) revealed a significant correlation in terms of diagnostic opportunity, vascular invasion, N factor, pathological stage and tumour location. However, between the two groups of 0-15 and >15 years, a significant correlation was identified only in diagnostic opportunity, the presence of primary sclerosing cholangitis. Trend analysis of disease duration showed significant correlations between diagnostic opportunity, histological type, vascular invasion and tumour location, with no significant differences observed in prognostic outcomes.
CONCLUSION: Our analysis highlighted distinct histological and clinical features in the short-term and long-term disease groups, and these features appear to intensify with increased disease duration. Since no significant difference in prognosis was found, there may not be a need to distinguish between them in cancer treatment.